Aldeyra Therapeutics, Inc. (ALDX)
1.59
+0.04
(+2.58%)
USD |
NASDAQ |
May 21, 16:00
1.57
-0.02
(-1.26%)
After-Hours: 19:59
Aldeyra Therapeutics Research and Development Expense (TTM) : 20.65M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.420B |
| AbbVie, Inc. | 9.501B |
| Rhythm Pharmaceuticals, Inc. | 171.76M |
| Catalyst Pharmaceuticals, Inc. | 11.48M |
| ADMA Biologics, Inc. | 6.532M |